首页 » 全部 » 库存预测 » Entrada Therapeutics Inc. Common Stock 预测

Entrada Therapeutics Inc. Common Stock 预测: 明天, 下周, 下个月, 5年

已更新: April 22 · 2026 at 07:03 UTC

From

▼ -3.61%Market Cap $500.38M · Technical analysis Bearish · Focus area Price + volatility

预测总结

时间范围	预计价格	过去	历史	洞察
明天	$13.24 ▲ +1.33%	昨天	$13.00 ▼ -0.56%	Tomorrow's Entrada Therapeutics Inc. Common Stock (TRDA) setup is anchored to $13.07 and targets $13.24 (+1.33%). The near-term read is upside; watch $13.46 / $12.68 because daily realized volatility is about 6.84%.
Tomorrow's Entrada Therapeutics Inc. Common Stock (TRDA) setup is anchored to $13.07 and targets $13.24 (+1.33%). The near-term read is upside; watch $13.46 / $12.68 because daily realized volatility is about 6.84%.
下周	$13.61 ▲ +4.12%	上星期	$12.84 ▼ -1.73%	The 7-day Entrada Therapeutics Inc. Common Stock model moves from $12.84 to $13.61 (+4.12%). It gives upside momentum context for this stock, so breaks around $13.46 / $12.68 matter more than a single tick.
The 7-day Entrada Therapeutics Inc. Common Stock model moves from $12.84 to $13.61 (+4.12%). It gives upside momentum context for this stock, so breaks around $13.46 / $12.68 matter more than a single tick.
下个月	$14.22 ▲ +8.79%	上个月	$12.59 ▼ -3.69%	The 1-month Entrada Therapeutics Inc. Common Stock target is $14.22 (+8.79%), compared with the live reference near $13.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Entrada Therapeutics Inc. Common Stock target is $14.22 (+8.79%), compared with the live reference near $13.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
明年	$15.13 ▲ +15.77%	去年	$12.20 ▼ -6.62%	The 1-year Entrada Therapeutics Inc. Common Stock scenario points to $15.13 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Entrada Therapeutics Inc. Common Stock scenario points to $15.13 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年	$17.27 ▲ +32.14%	5年前	$11.31 ▼ -13.50%	The 5-year Entrada Therapeutics Inc. Common Stock view is $17.27 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Entrada Therapeutics Inc. Common Stock view is $17.27 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

明天$13.24▲ +1.33%

昨天$13.00▼ -0.56%

Tomorrow's Entrada Therapeutics Inc. Common Stock (TRDA) setup is anchored to $13.07 and targets $13.24 (+1.33%). The near-term read is upside; watch $13.46 / $12.68 because daily realized volatility is about 6.84%.

下周$13.61▲ +4.12%

上星期$12.84▼ -1.73%

The 7-day Entrada Therapeutics Inc. Common Stock model moves from $12.84 to $13.61 (+4.12%). It gives upside momentum context for this stock, so breaks around $13.46 / $12.68 matter more than a single tick.

下个月$14.22▲ +8.79%

上个月$12.59▼ -3.69%

The 1-month Entrada Therapeutics Inc. Common Stock target is $14.22 (+8.79%), compared with the live reference near $13.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

明年$15.13▲ +15.77%

去年$12.20▼ -6.62%

The 1-year Entrada Therapeutics Inc. Common Stock scenario points to $15.13 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5年$17.27▲ +32.14%

5年前$11.31▼ -13.50%

The 5-year Entrada Therapeutics Inc. Common Stock view is $17.27 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

价格走势图

历史预报看涨看跌

技术分析

Neutral

看涨

中性

看跌

关键指标

指标	价值	信号
Price	$13.07	Mid
Daily Change	-3.61%	Below
Volatility Cap	20.0%	Mid
Confidence	65%	Above
Data Source	nasdaq-screener	Mid

历史数据

Current$13.07

Daily Change-3.61%

Market Cap$500.38M

Sourcenasdaq-screener

Current	$13.07	Daily Change	-3.61%
Market Cap	$500.38M	Source	nasdaq-screener

支撑位和阻力位

$12.68Support 1

$13.07当前

$13.46Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

价格里程碑

关键层面和历史背景

Current$13.07Live reference price

Used as the anchor for generated forecast calculations.

Next Month$14.22Model projection+8.79%

Directional scenario based on capped drift.

预测准确度

我们的模型表现如何

65%

定向

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

我们的算法每周使用最新的价格行为、波动机制和指标信号进行重新校准。准确性因时间范围而异——短期势头比长期预测更可靠。

Short term

65%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

投资场景

如果您今天投资 $1,000 于 TRDA

Bullish Scenario

$13.72

+5.00% from current

目标价格$13.72

设想Upside momentum

可能性57%

Base Scenario

$14.22

+8.79%

目标价格$14.22

设想Capped drift

可能性65%

Bearish Scenario

$12.42

-5.00% from current

目标价格$12.42

设想Volatility drawdown

可能性35%

基础: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

预测因素

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 69/100

24H drift+1.33%

7D drift+4.12%

30D drift+8.79%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 66/100

1M outlook+8.79%

1Y outlook+15.77%

5Y outlook+32.14%

常见问题解答

Q What is the Entrada Therapeutics Inc. Common Stock (TRDA) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Entrada Therapeutics Inc. Common Stock is projected near $13.24 versus the current reference around $13.07. That implies a modeled move of +1.33% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TRDA?

The weekly Entrada Therapeutics Inc. Common Stock model points to $13.61, which maps to an expected drift of +4.12% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Entrada Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Entrada Therapeutics Inc. Common Stock 1-month target is $14.22 (+8.79%), while the 1-year target is $15.13 (+15.77%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Entrada Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Entrada Therapeutics Inc. Common Stock long-horizon scenario sits near $17.27 with a modeled change of +32.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TRDA support and resistance zones right now?

For Entrada Therapeutics Inc. Common Stock, nearest resistance is around $12.68, while nearest support is around $13.46. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Entrada Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.